Johnson NR, Yuan P, Castillo E, Lopez TP, Yue W, Bond A, Rivera BM, Sullivan MC, Hirouchi M, Giles K, Aoyagi A, Condello C. CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model. Nat Commun. 2023 Jan 9;14(1):118. PubMed PMID: 36624100
Johnson NR, Wang ACJ, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aß and show evidence of improving Alzheimer’s disease cognition. Alz Res Ther. 2022, 14(1):88. PMID: 35768831.
Johnson NR. Tau acetylation reduces its autophagic degradation and is a targetable pathway for human tauopathies. BioEssays. 2022, 44(6):2200062. PMID: 35445427.
Wong DR, Conrad J*, Johnson NR*, Ayers J, Laeremans A, Lee JC, Lee J, Prusiner SB, Bandyopadhyay S, Butte AJ, Paras NA, Keiser MJ. Trans-channel fluorescence learning improves high-content screening for Alzheimer’s disease therapeutics. Nat Mach Intell. 2022, 4:583–595.
Lucero EM, Freund RK, Johnson NR, Dooling B, Sullivan E, Prikhodko O, Ahmed MM, Dell'Acqua ML, Chial HJ, Potter H. Kif11 overexpression rescues cognition, long-term potentiation, and spine defects in mouse and cell models of Alzheimer's disease. iScience. 2022, 25(11):105288. PMID: 36304124, PMCID: PMC9593841.
Rocker AJ, Cavasin M, Johnson NR, Shandas R, Park D. A Sulfonated Thermoresponsive Injectable Gel for Sequential Release of Therapeutic Proteins to Protect Cardiac Function After a Myocardial Infarction. ACS Biomater Sci Eng. 2022, 8(9):3883–3898. PMID: 35950643.
Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aß and show evidence of improving Alzheimer's disease cognition. Alzheimers Res Ther. 2022 Jun 29;14(1):88. PubMed PMID: 35768831
Ahmed MM, Johnson NR, Boyd TD, Coughlan C, Chial HJ, Potter H. Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?. Front Aging Neurosci. 2021;13:718426. PubMed PMID: 34603007
Johnson NR, Kruger M, Goetsch KP, Zilla P, Bezuidenhout D, Wang Y, Davies NH. Coacervate Delivery of Growth Factors Combined with a Degradable Hydrogel Preserves Heart Function after Myocardial Infarction. ACS Biomater Sci Eng. 2015 Sep 14;1(9):753-759. PubMed PMID: 33445252
Johnson NR, Wang Y. Controlled Delivery of Sonic Hedgehog with a Heparin-Based Coacervate. Methods Mol Biol. 2015;1322:1-7. PubMed PMID: 26179034
Johnson NR, Ambe T, Wang Y. Lysine-based polycation:heparin coacervate for controlled protein delivery. Acta Biomater. 2014 Jan;10(1):40-6. PubMed PMID: 24075887
Li H, Johnson NR, Usas A, Lu A, Poddar M, Wang Y, Huard J. Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells. Stem Cells Transl Med. 2013 Sep;2(9):667-77. PubMed PMID: 23884640
Johnson NR, Wang Y. Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing. J Control Release. 2013 Mar 10;166(2):124-9. PubMed PMID: 23154193
Johnson NR, Wang Y. Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair. PLoS One. 2013;8(5):e63075. PubMed PMID: 23690982
Upadhyayula S, Quinata T, Bishop S, Gupta S, Johnson NR, Bahmani B, Bozhilov K, Stubbs J, Jreij P, Nallagatla P, Vullev VI. Coatings of polyethylene glycol for suppressing adhesion between solid microspheres and flat surfaces. Langmuir. 2012 Mar 20;28(11):5059-69. PubMed PMID: 22364506
Chu H, Johnson NR, Mason NS, Wang Y. A [polycation:heparin] complex releases growth factors with enhanced bioactivity. J Control Release. 2011 Mar 10;150(2):157-63. PubMed PMID: 21118705